InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,223.99
(
0.33%
)
Post# of 252190
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: DewDiligence post# 181019

Thursday, 08/07/2014 9:13:55 AM

Thursday, August 07, 2014 9:13:55 AM

Post# of 252190

ENTA—Today's announcement of the clinical advancement of EDP-239 (#msg-105063800) is probably the reason ENTA's CSO exercised options two days ago without selling the new shares.



I am not sure that I understand. Are you saying that this news was not expected soon and should cause the shares to rise quite a bit? The first milestone of $15 million is not due for quite a while, so there is no immediate benefit to the bottom line. Thanks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up